Lubomir Sokol Selected Research

Lubomir Sokol Research Topics

Disease

27	Neoplasms (Cancer) 02/2024 - 08/2003
12	Lymphoma (Lymphomas) 01/2023 - 08/2003
12	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2018 - 01/2006
10	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 05/2024 - 09/2010
10	Large Granular Lymphocytic Leukemia 10/2023 - 08/2003
7	T-Cell Lymphoma (Lymphoma, T Cell) 01/2023 - 08/2003
7	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2022 - 01/2014
6	Infections 01/2023 - 09/2013
6	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 07/2009
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2017 - 07/2012
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2024 - 12/2011
5	Mycosis Fungoides 01/2023 - 06/2014
5	Leukemia 01/2018 - 08/2003
4	Hodgkin Disease (Hodgkin's Disease) 11/2023 - 02/2017
4	Anemia 10/2023 - 11/2007
4	Thrombocytopenia (Thrombopenia) 01/2023 - 07/2002
4	Cytopenia 01/2018 - 08/2003
4	B-Cell Lymphoma (Lymphoma, B Cell) 09/2016 - 07/2012
3	Disease Progression 02/2024 - 08/2003
3	Peripheral Nervous System Diseases (PNS Diseases) 11/2023 - 03/2014
3	Fever (Fevers) 11/2023 - 07/2013
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 08/2003
3	Lymphadenopathy 11/2020 - 04/2003
3	Multiple Myeloma 01/2018 - 12/2006
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2018 - 08/2014
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2017 - 08/2010
2	Lung Injury 11/2023 - 01/2019
2	Neutropenia 11/2023 - 10/2023
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2023 - 01/2016
2	Enteropathy-Associated T-Cell Lymphoma 01/2022 - 11/2017
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2022 - 11/2017
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019 - 01/2018
2	Sepsis (Septicemia) 01/2018 - 04/2003
2	Hepatitis B 01/2018 - 02/2017
2	Castleman Disease (Castleman's Disease) 07/2013 - 08/2010
2	Fatigue 07/2013 - 04/2013
2	Bone Marrow Failure Disorders 05/2012 - 02/2011
1	Plasmablastic Lymphoma 02/2024
1	COVID-19 06/2023
1	Blast Crisis (Blast Phase) 01/2023
1	Eosinophilia 01/2023
1	Inflammation (Inflammations) 01/2023
1	Leukopenia 01/2023
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 09/2022
1	Pathologic Complete Response 05/2021

Drug/Important Bio-Agent (IBA)

9	romidepsin (FK228)FDA Link 10/2019 - 02/2012
8	Lenalidomide (CC 5013)FDA Link 02/2024 - 12/2006
7	Histone Deacetylase InhibitorsIBA 01/2021 - 01/2014
6	Monoclonal AntibodiesIBA 01/2018 - 08/2010
5	Proteins (Proteins, Gene)FDA Link 09/2018 - 04/2005
5	Rituximab (Mabthera)FDA Link 10/2017 - 07/2012
4	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 08/2003
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2023 - 01/2016
3	mogamulizumabIBA 01/2022 - 03/2015
3	Vorinostat FDA Link 12/2020 - 01/2018
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2018 - 09/2013
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016 - 08/2003
2	Biomarkers (Surrogate Marker)IBA 02/2024 - 09/2018
2	Brentuximab VedotinIBA 11/2023 - 01/2019
2	Bleomycin (Blenoxane)FDA LinkGeneric 11/2023 - 01/2019
2	Vinblastine (Vinblastine Sulfate)FDA Link 11/2023 - 01/2019
2	Dacarbazine (DIC)FDA LinkGeneric 11/2023 - 01/2019
2	CytokinesIBA 10/2023 - 04/2012
2	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 01/2016
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 04/2013
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2022
2	SteroidsIBA 01/2023 - 04/2017
2	Anaplastic Lymphoma KinaseIBA 01/2022 - 11/2017
2	MethyltransferasesIBA 01/2021 - 01/2021
2	pembrolizumabIBA 01/2020 - 01/2020
2	InflammasomesIBA 09/2018 - 12/2016
2	Antiviral Agents (Antivirals)IBA 01/2018 - 02/2017
2	Histone Deacetylases (Histone Deacetylase)IBA 06/2016 - 03/2016
2	siltuximabIBA 07/2013 - 08/2010
2	MicroRNAs (MicroRNA)IBA 03/2013 - 04/2011
2	EpitopesIBA 05/2012 - 04/2005
2	Peptides (Polypeptides)IBA 05/2012 - 04/2005
2	Farnesyltranstransferase (Farnesyltransferase)IBA 04/2012 - 12/2008
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2006 - 08/2003
1	ofatumumab FDA Link 02/2024
1	Methylprednisolone FDA LinkGeneric 02/2024
1	B-Cell Maturation AntigenIBA 02/2024
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2023
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2023
1	Asparaginase (Elspar)FDA Link 01/2023
1	Ifosfamide FDA LinkGeneric 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	cc-486IBA 01/2023
1	Inosine Triphosphate (ITP)IBA 09/2022
1	tagraxofuspIBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2021

Therapy/Procedure

44	Therapeutics 02/2024 - 04/2003
12	Drug Therapy (Chemotherapy) 02/2024 - 08/2003
8	Cell Transplantation 05/2024 - 11/2017
4	Induction Chemotherapy 01/2019 - 04/2003
3	Immunotherapy 01/2018 - 08/2014
2	Radiotherapy 06/2023 - 08/2003
2	Hematopoietic Stem Cell Transplantation 01/2019 - 01/2018
1	Secondary Prevention 01/2023